Showing results (161-170 of 184) with videos related to
Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2014
Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for LeukemiaMichael Boyiadzis, Mukta Arora, John P Klein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2021
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant CyclophosphamideBronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantationKaren K Ballen, Brent R Logan, Mary J Laughlin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationMonzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.Transplantation and Cellular Therapy|December 30, 2022
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical TrialBronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, et al.American Journal of Human Genetics|February 1, 2020
Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic AnemiaSharon A Savage, Mathias Viard, Colm O'hUigin, et al.JCO Oncology Practice|February 13, 2020
Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid LeukemiaJohn M Pagel, Megan Othus, Guillermo Garcia-Manero, et al.JCI Insight|October 11, 2022
Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicitiesTimothy S Olson, Benjamin F Frost, Jamie L Duke, et al.Transplantation and Cellular Therapy|June 29, 2024
Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research RegistryRachel Cusatis, Carlos Litovich, Zhongyu Feng, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2015
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic AnemiaYoshihiro Inamoto, Mary E D Flowers, Tao Wang, et al.Pageof 19